Cameron Turtle

Chief Executive Officer, Director, Spyre Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$11.4M

Companies

Latest trade

Oct 1, 2026

Companies

Spyre Therapeutics, Inc.Chief Executive Officer, Director −$11.4M

Trades

SYRE Sold 15,000 shares at $92.01 · planned $1.4M Oct 1

SYRE Sold 15,000 shares at $87.29 · planned $1.3M Sep 1

SYRE Sold 15,000 shares at $95.51 · planned $1.4M Aug 3

SYRE Sold 15,000 shares at $87.69 · planned $1.3M Jul 1

SYRE Sold 15,000 shares at $70.43 · planned $1.1M Jun 1

SYRE Sold 15,000 shares at $71.37 · planned $1.1M May 1

SYRE Sold 15,000 shares at $49.33 · planned $0.7M Apr 1

SYRE Sold 15,000 shares at $42.19 · planned $0.6M Mar 2

SYRE Sold 15,000 shares at $32.80 · planned $0.5M Feb 2

SYRE Sold 15,000 shares at $30.68 · planned $0.5M Jan 2

SYRE Sold 15,000 shares at $29.02 · planned $0.4M Dec 1

SYRE Sold 45,000 shares at $23.33 · planned $1.0M Nov 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.